The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells

Blood

Volumn 106, Issue 2, 2005, Pages 698-705

  Chen, Qing ^a   Van Der Sluis, Pieter C ^a   Boulware, David ^a   Hazlehurst, Lori A ^a   Dalton, William S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

ARTICLE; CELL CYCLE; COMET ASSAY; CONTROLLED STUDY; DNA CROSS LINKING; DRUG EFFICACY; DRUG SENSITIVITY; DRUG USE; FANCONI ANEMIA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 22144466584     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-11-4286     Document Type: Article

References (45)

1. Dronkert ML, Kanaar, R. Repair of DNA interstrand cross-links. Mutat Res. 2001;486:217-247.
2. Bellamy WT, Dalton, WS, Gleason, MC, Grogan, TM, Trent, JM. Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res. 1991;51:995-1002.
3. Hazlehurst LA, Enkemann, SA, Beam, CA, et al. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res. 2003;63:7900-7906.
4. D'Andrea AD, Grompe, M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23-34.
5. Sasaki MS, Takata, M, Sonoda, E, Tachibana, A, Takeda, S. Recombination repair pathway in the maintenance of chromosomal integrity against DNA interstrand crosslinks. Cytogenet Genome Res. 2004;104:28-34.
6. Lo Ten Foe JR, Rooimans, MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet. 1996;14:320-323.
7. Meetei AR, Levitus, M, Xue, Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet. 2004;36:1219-1224.
8. Strathdee CA, Gavish, H, Shannon, WR, Buchwald, M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992; 356:763-767.
9. Wang X, Andreassen, PR, D'Andréa, AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol. 2004;24:5850-5862.
10. Timmers C, Taniguchi, T, Hejna, J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
11. de Winter JP, Leveille, F, van Berkel, CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306-1308.
12. de Winter JP, Rooimans, MA, van DerWeel L, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
13. de Winter JP, Waisfisz, Q, Rooimans, MA, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281-283.
14. Meetei AR, de Winter, JP, Medhurst, AL, et al. A novel ubiquitin.ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170.
15. Freie BW, Ciccone SL, Li X, et al. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint. J Biol Chem. 2004;279:50986-50993.
16. Kruyt FA, Hoshino, T, Liu, JM, Joseph, P, Jaiswal, AK, Youssoufian, H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 1998;92:3050-3056.
17. Fagerlie SR, Diaz, J, Christianson, TA, et al. Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes. Blood. 2001;97:3017-3024.
18. Pang Q, Christianson, TA, Keeble, W, et al. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood. 2001;98:1392-1401.
19. Pang Q, Christianson TA, Keeble, W, Koretsky T, Bagby GC. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J Biol Chem. 2002;277:49638-49643.
20. Pang Q, Keeble, W, Christianson, TA, Faulkner, GR, Bagby, GC. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha- mediated cytotoxicity. EMBO J. 2001; 20:4478-4489.
21. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol. 2004;24:123-134.
22. Pichiem P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. Embo J. 2004; 23:1178-1187.
23. Pichierri P, Rosselli, F. Fanconi anemia proteins and the s phase checkpoint. Cell Cycle. 2004;3:698-700.
24. Rosselli F, Briot D, Pichierri P. The Fanconi anemia pathway and the DNA interstrand cross-links repair. Biochimie. 2003;85:1175-1184.
25. Pu QQ, Bezwoda WR. Induction of alkylator (meiphalan) resistance in HL60 cells is accompanied by increased levels of topoisomerase II expression and function. Mol Pharmacol. 1999;56:147-153.
26. Spanswick VJ, Craddock C, Sekhar M, et al. Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood. 2002;100:224-229.
27. Bolick SC, Landowski TH, Boulware D, et al. The famesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells. Leukemia. 2003;17:451-457.
28. Damiano JS, Cress, AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93:1658-1667.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
30. Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene. 2000;19:4319-4327.
31. Soulier J, Leblanc T, Larghero J, et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood. 2005;105:1329-1336.
32. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 2002; 100:2414-2420.
33. Akkari YM, Bateman RL, Reifsteck CA, D'Andrea AD, Olson SB, Grompe M. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol Genet Metab. 2001;74:403-412.
34. Grompe M, D'Andrea A. Fanconi anemia and DNA repair. Hum Mol Genet. 2001;10:2253-2259.
35. Femberg JO, Lewensohn R, Skog S. Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226. Eur J Haematol. 1991;47:161-167.
36. Osborne MR, Lawley PD. Alkylation of DNA by melphalan with special reference to adenine derivatives and adenine-guanine cross-linking. Chem Biol Interact. 1993;89:49-60.
37. Souliotis VL, Dimopoulos MA, Sfikakis PP. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards. Clin Cancer Res. 2003;9:4465-4474.
38. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568-574.
39. D'Andrea AD. The Fanconi road to cancer. Genes Dev. 2003;17:1933-1936.
40. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004; 23:1000-1004.
41. Narayan G, Arias-Pulido H, Nandula SV, et al. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 2004;64:2994-2997.
42. Leveille F, Blom E, Medhurst AL, et al. The Fanconi anemia gene product FANCF is a flexible adaptor protein. J Biol Chem. 2004;279:39421-39430.
43. Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Exp Hematol. 2001;29:1448-1455.
44. Wang J, Otsuki T, Youssoufian H, et al. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Res. 1998;58:3538-3541.
45. Fabio T, Crescenzio N, Saracco P, Leone L, Ponzio G, Ramenghi U. Cell cycle analysis in the diagnosis of Fanconi's anemia. Haematologica. 2000;85:431-432.